English 
Spanish 
Chinese 
Russian 
German 
French 
Portuguese 
Hindi 当社グループは 3,000 以上の世界的なカンファレンスシリーズ 米国、ヨーロッパ、世界中で毎年イベントが開催されます。 1,000 のより科学的な学会からの支援を受けたアジア および 700 以上の オープン アクセスを発行ジャーナルには 50,000 人以上の著名人が掲載されており、科学者が編集委員として名高い
。オープンアクセスジャーナルはより多くの読者と引用を獲得
700 ジャーナル と 15,000,000 人の読者 各ジャーナルは 25,000 人以上の読者を獲得
インデックス付き
- Google スカラー
- ICMJE
役立つリンク
オープンアクセスジャーナル
このページをシェアする
抽象的な
The Clinical Manifestations, Biochemical Markers, and Cerebral Structures of Patients with Major Depressive Disorder
William Strahan
Depressive disorder (DD) was viewed as a temporary and natural mood disorder for a long time. Biochemical changes in the monoamines and their receptors were thought to be primarily to blame for its etiology. Despite this, the disease’s prevalence and significant impact on the family and social environment of those who suffer from it have made it a global public health issue. The clinical manifestations, biochemical markers, and cerebral structures of patients with major depressive disorder (MDD), which frequently overlap with neurodegenerative disorders, show changes in several psychiatric conditions that are referred to as neuroprogression. Apoptosis, decreased neurogenesis, decreased neuronal plasticity, and an increased immune response are all thought to occur in DD, making it a potentially aggressive form of neuronal deterioration.